Status:
RECRUITING
Exercise Snacks in Obesity
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
McMaster University
Conditions:
Obesity
Eligibility:
All Genders
35-64 years
Phase:
NA
Brief Summary
To conduct a randomized control trial to determine the feasibility and preliminary efficacy of a 12-week technology-enabled exercise snacks intervention with behaviour change counselling for improving...
Detailed Description
Participants will be randomized into an Exercise Snacks or a Placebo Exercise group for 12 weeks. The former will involve bodyweight exercises performed with vigorous effort and the latter will involv...
Eligibility Criteria
Inclusion
- Aged 35-64 years.
- Habitually engaging in \< 150 min moderate-to-vigorous physical activity per week.
- Body mass index 30-45 kg/m2 or 27.5-45 for participants who self-identify as being of Asian or Southeast Asian origin.
- Waist circumference: \>88cm for females and \>102cm for males, or \>80 cm for females and \>90 cm for male participants who self-identify as being of Asian or Southeast Asian.
- Not currently diagnosed with a cardiometabolic disease (e.g., coronary artery disease, stroke, diabetes, non-alcoholic fatty liver disease).
- Taking ≤2 commonly prescribed medications for the prevention of cardiometabolic diseases (e.g., statins, antihypertensives).
- Not a current smoker
- Cleared to engage in physical activity using the Get Active Questionnaire and, if applicable, consultation with a health care provider or Qualified Exercise Professional.
- Access to a computer, tablet or smartphone for intervention delivery and tracking.
- Ability to read and write in English.
Exclusion
- Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise.
- Lack of internet access.
- Angina upon exertion assessed by the Rose Angina Questionnaire.
- Prescribed beta-blockers that can compromise the validity of heart rate measurements. during the exercise test.
- Have a scheduled surgical procedure within the next 3-4 months that would prevent exercise participation.
- Currently participating in another clinical trial that interferes with the study procedures.
- Currently pregnant or planning on becoming pregnant during the intervention (i.e., within the next 4 months).
- Uncontrolled high blood pressure (\>160/90 mmHg)
Key Trial Info
Start Date :
July 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06924346
Start Date
July 14 2025
End Date
May 1 2026
Last Update
July 22 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan
Kelowna, British Columbia, Canada
2
McMaster University
Hamilton, Ontario, Canada